The Top Dividend Growth stock model aims to deliver optimal total return with reliable growth factors and high dividends for higher profitability long-term. Only one stock of the 15 largest Mega Cap s...
Despite high market multiples, the Eli Lilly stock has outperformed the S&P 500 Health Care Index YTD, and this might just continue. Strong Q1 2024 performance leading to an upgraded guidance for the ...
These profitable businesses are leaders in their respective healthcare sectors. Intuitive Surgical is the global market leader in surgical robotics, with a sneaky recurring revenue model....
Eli Lilly has been working on a drug called donanemab to treat Alzheimer's disease. This market is estimated to reach more than $30 billion by the next decade....
Eli Lilly is partnering with OpenAI to help research antimicrobial resistance (AMR) treatments. Research suggests that AI in the healthcare market could be a $187 billion opportunity by 2030....
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs. Just look at Eli Lilly (NYSE: LLY )....
Healthcare stocks to buy have been off to the races recently — especially the ones in the weight-loss drug market. Indeed, the market is huge and could entail considerable growth for many years into...
This has been a very good year for the stock market as a whole, although the performance of broad U.S. indexes also underscores how important the weighting of an index can be....
Weight loss drugs have taken the pharmaceutical and medical communities by storm. Not only are the companies behind the medications struggling to keep up with global demand, but reports are emerging t...
Eli Lilly's shares have soared more than 50% this year to about $900. This level may discourage some investors from hitting the buy button....
3 Biotech Stocks For The Second Half Of 2024...